Rare Disease Trial, Not Yet Recruiting NCT07650799 Sponsor: Peking Union Medical College Hospital Condition: Rare Disease
Back to Rare Disease

Rare Disease Trial, Not Yet Recruiting

NCT07650799
Not Yet Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People of any age can apply; if the person is a child or cannot make decisions for themselves, a parent or legal guardian can sign the consent forms on their behalf.
  • You have an illness or condition that doctors have not been able to diagnose, and it is thought to possibly be a rare disease.
  • You have had at least one full medical evaluation at a hospital or specialist clinic before, but no clear diagnosis was found.
  • This would be your first visit to the hospital or clinic running this trial for this particular condition, with no previous records there.
  • You have not had any genetic testing done related to your current unexplained condition.
  • You are willing and able to attend follow-up appointments as required by the trial, and you agree to this in writing.

Who may not be able to join:

  • You already have a confirmed diagnosis — whether from clinical assessment, lab tests, or genetic results — that explains your main symptoms.
  • You are in a medical emergency, seriously unwell, or have any condition that would make taking part unsafe or unsuitable.
  • Neither you nor someone legally authorised to act on your behalf is able to complete the required follow-up visits.
  • You are currently taking part in another clinical study that is also looking at diagnosis accuracy or genetic testing as a main goal.
  • An AI system has already been used and has produced a confirmed diagnosis for your current condition.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Shuyang Zhang, MD, PhD, Peking Union Medical College Hospital

Phone: +86-13911667211

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2026
Est. completion
1 July 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Overall Correct Diagnostic Yield

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov